Drug profile · INN
methyl aminolevulinate hydrochloride
METVIXIA
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
methyl aminolevulinate hydrochloride (METVIXIA) is an FDA-listed pharmaceutical active ingredient. Route of administration: topical. Current US regulatory status: approved.
Key facts
INN methyl aminolevulinate hydrochloride
Brand METVIXIA
Route TOPICAL
Formulation CREAM
Frequently asked questions
What is methyl aminolevulinate hydrochloride?
methyl aminolevulinate hydrochloride (METVIXIA) is an FDA-listed pharmaceutical active ingredient. Route of administration: topical. Current US regulatory status: approved.
What is the brand name for methyl aminolevulinate hydrochloride?
METVIXIA is a marketed brand name for methyl aminolevulinate hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of methyl aminolevulinate hydrochloride?
methyl aminolevulinate hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.